Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Posard Matthew L.director |
Sell | 10,000 @ $50.62 | $506,190 | 99,755 | 06/12/2024 | 06/13/2024 | |
Posard Matthew L.director |
Sell | 10,000 @ $50.01 | $500,110 | 109,755 | 06/11/2024 | 06/13/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $45.38 | $453,840 | 168,176 | 05/22/2024 | 05/22/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $45.16 | $451,640 | 168,176 | 05/21/2024 | 05/22/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $38.49 | $384,890 | 168,176 | 04/17/2024 | 04/17/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $38.35 | $383,500 | 168,176 | 04/16/2024 | 04/17/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $42.27 | $422,730 | 156,558 | 03/13/2024 | 03/13/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $41.64 | $416,370 | 156,558 | 03/12/2024 | 03/13/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 2,529 @ $39.56 | $100,045 | 156,558 | 02/28/2024 | 02/28/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 7,471 @ $39.54 | $295,418 | 156,558 | 02/28/2024 | 02/28/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $39.95 | $399,460 | 159,087 | 02/27/2024 | 02/28/2024 | |
LaBarre Michael J.SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $36.00 | $360,000 | 151,911 | 01/17/2024 | 01/18/2024 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at Halozyme Therapeutics, Inc. includes LaBarre Michael J., Posard Matthew L..
A. Insiders have sold a total of 110,000 Halozyme Therapeutics, Inc. shares in the last 12 months for a total of 4.67 M sold.
A. The following insiders have sold Halozyme Therapeutics, Inc. shares in the last 12 months: LaBarre Michael J. ($3.67 M), Posard Matthew L. ($1.01 M),